Skip to main content
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: ChemMedChem. 2015 Jul 1;11(2):154–165. doi: 10.1002/cmdc.201500188

Figure 4.

Figure 4

Design of MD2-based TLR4 antagonists utilizes the structural similarity of agonists and MD2, which results in competition between antagonists and MD2 for TLR4 binding. For TLR4 binding with antagonists, such as MD2-I, the formation of the MD2-TLR4 complex may be blocked.